Clinical utility of <sup>177</sup>Lu‐DOTATATE PRRT in somatostatin receptor‐positive metastatic medullary carcinoma of thyroid patients with assessment of efficacy, survival analysis, prognostic variables, and toxicity - Concepedia

Concepedia

Publication | Closed Access

Clinical utility of <sup>177</sup>Lu‐DOTATATE PRRT in somatostatin receptor‐positive metastatic medullary carcinoma of thyroid patients with assessment of efficacy, survival analysis, prognostic variables, and toxicity

66

Citations

35

References

2019

Year

Rahul V. Parghane, Chinna Naik, Sanjay Talole, Anuja Desmukh, Devendra Chaukar, Sharmila Banerjee, Sandip Basu

Abstract

The results demonstrated that, <sup>177</sup> Lu-DOTATATE is a potentially efficacious and safe therapeutic option in SSTR avid metastatic MTC patients.

References

	Year	Citations

Page 1